I have decided to check the best stocks of 2014 so far, to see what I have missed this year. The minimum market cap criterion was $300 million, I also examined if they turned a profit or were bought by insiders prior to the big moves. Here are the best 30 stocks of 2014:
Ticker Name Sector YTD Gain (%) Market cap (mil.) Profit Insider
| Idenix Pharmaceuticals Inc. Pernix Therapeutics Intercept Pharmaceuticals Plug Power Inc. Pacific Ethanol, Inc. InterMune Inc. UBIC, Inc. Ballard Power Systems Inc. Prosensa Holding N.V. GW Pharmaceuticals plc Sequential Brands Group Furiex Pharmaceuticals Edenor SA Emerge Energy Services LP TG Therapeutics, Inc. Sibanye Gold Limited Achillion Pharmaceuticals Vital Therapies, Inc. Vipshop Holdings Limited Augusta Resource Corp. Pioneer Energy Services GT Advanced Technologies Accelerate Diagnostics MannKind Corp. Horizon Pharma, Inc. BioDelivery Sciences Karyopharm Therapeutics Phillips 66 Partners LP Platform Specialty Prod. Alder Biopharmaceuticals | Healthcare Healthcare Healthcare Technology Materials Healthcare Technology Industrial Healthcare Healthcare Consumer Healthcare Utilities Materials Healthcare Materials Healthcare Healthcare Services Materials Materials Technology Healthcare Healthcare Healthcare Healthcare Healthcare Materials Materials Healthcare | 303 256 247 202 200 200 175 171 170 158 156 153 149 148 141 137 128 127 124 122 119 113 113 111 108 105 103 101 100 100 | 3635.5 339.3 5004.7 782.1 307.9 4365.6 2487.9 533.2 453.1 2092.2 354.9 1148.9 342.3 2500.1 353.4 2438.7 732.8 593.6 10609.2 462.85 1100.64 2551.36 1159.08 4259.28 1166.41 584.79 1385.33 5589.17 3848.24 618.16 | No No No No No No No No No No Yes No Yes Yes No Yes No No Yes No No No No No No No No Yes No No | Yes No No Yes Yes Yes No Yes No No No Yes No Yes Yes No Yes Yes No No Yes No Yes Yes Yes Yes Yes Yes No No |
As you can see, 24 out of 30 top stocks (80%) didn't make any profit last year and most of them don't pay any dividend. So much for P/E ratios and dividend valuation models. In addition, 17 stocks (56%) were bought by insiders before their advance began. The most dominant sector was healthcare (or biotechnology) with 16 stocks, followed by basic materials (7).
However, there is one thing that all best stocks had in common: they kept making 52-week highs over and over during their big moves (simple, isn't it?), and some had huge increases in sales which justified the skyrocketing prices.
RSS Feed